Signaling Pathways
-
A1659 DutasterideTarget: 5-alpha ReductasesSummary: 5-alpha-reductase inhibitor
-
A2451 Epirubicin HClTarget: TopoisomerasesSummary: Antibiotic antitumor agent
-
A1980 SNS-032 (BMS-387032)2 CitationTarget: Cyclin-Dependent KinasesSummary: CDK inhibitor
-
A1196 SGX-5231 CitationTarget: METSummary: MET inibitor, highly selective, ATP-competitive
-
A5112 XL147Target: PI3KSummary: PI3K inhibitor,selective and reversible
-
A2681 TGX-221Target: PI3KSummary: PI3Kβ inhibitor,potent,selective and ATP competitive
-
A2949 Linifanib (ABT-869)Target: VEGFR|PDGFRSummary: VEGFR/PDGFR inhibitor
-
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: IGF-1R/InsR inhibitor,potent and selective
-
A5078 KU-0063794Target: mTORSummary: MTORC1 and mTORC2 inhibitor
-
A1805 Imatinib Mesylate (STI571)Target: PDGFR|c-Kit|Bcr-AblSummary: Abl/c-kit/PDGFR inhibitor